Pharmagreen Biotech, Inc. (PHBI)
0.0015
0.00 (0.00%)
USD |
OTCM |
Apr 01, 16:00
Pharmagreen Biotech Enterprise Value : 1.014M for April 1, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Hear AtLast Holdings, Inc. | 3.509M |
| CeCors, Inc. | -- |
| Venus Concept, Inc. | 27.75M |
| Achieve Life Sciences, Inc. | 145.72M |
| Oncolytics Biotech, Inc. | 96.70M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -1.102M |
| Revenue (Quarterly) | 3.422M |
| Total Expenses (Quarterly) | 4.524M |
| EPS Diluted (Quarterly) | -0.0017 |
| Profit Margin (Quarterly) | -32.19% |
| Earnings Yield | -49.78% |
| Normalized Earnings Yield | -99.56 |